Lumenis Ltd. – a global leader specialized in minimally-invasive clinical solutions in the field of ophthalmology and in energy-based technologies, including Laser, Intense Pulse Light (IPL) and Radio-Frequency (RF) – participated in the 3rd Annual Worldwide EndoMarch, an international event to raise endometriosis awareness.
EndoMarch was hosted March 19 in cities around the world, including New York, Washington, D.C., and San Francisco – where the largest chapter event took place and Lumenis employees participated – and in Portugal, Germany, India, Nigeria, Brazil, and Australia.
Since its start, the EndoMarch movement has supported and encouraged thousands of women around the globe to unite in raising awareness about endometriosis, a condition of the endometrium with symptoms associated with pelvic pain and infertility in up to 50 percent of the women who suffer from it.
“Endometriosis impacts 1 in 10 women, which is approximately 200 million women worldwide,” Lumenis CEO Tzipi Ozer-Armon said in a press release. “The recently launched UltraPulse DUO system demonstrates once again our commitment to developing the best technology that improves gynecological-related health conditions. In addition to innovative technological solutions, we are very involved in patient education efforts. We believe that EndoMarch is an ideal platform to empower and educate women about endometriosis, its symptoms, risks, and the treatment options available, and we are pleased to be part of this annual international event.”
Even though there is currently no cure for endometriosis, Lumenis’ UltraPulse and AcuPulse technologies are earning respect from leading endometriosis surgeons for their superior quality. These technologies are capable of operating with unique precision around delicate anatomy with minimal thermal damage while preserving healthy tissue. The procedure results in less time needed to heal from surgery and lower recurrence rates. Fertility preservation rates may also be improved after the CO2 laser treatment.
“While endometriosis is a treatable condition, it continues to be one of the most ignored public health crises of our time,” said Camran Nezhat, M.D., FACOG, FACS, and the founder of the Worldwide EndoMarch. “Because the majority of women overlook their endometriosis symptoms and attribute them to other causes, women often face diagnostic delays of 10 years or more. These diagnostic delays may result in increased severity of the condition and fertility challenges.”
“As a global initiative, EndoMarch calls on all women, those fighting endometriosis and their supporters, to join together to raise awareness around this serious disease. Beyond disease awareness, it is especially important for women to be informed about endometriosis treatment options and Lumenis CO2 laser technology, one of the advanced options for better patient care,” Nezhat said.
Photo Credits: www.endomarch.org